ContraFect Invited to Present at the Inaugural Anti-Infectives Drug Development Summit
YONKERS, N.Y., April 15, 2021 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the…
Pharmaceuticals, Biotechnology and Life Sciences
YONKERS, N.Y., April 15, 2021 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the…
New Zealand Ministry of Health Proposal Calls for Reducing Nicotine Content in Cigarettes to “Minimal Levels” to Help Smokers Quit,…
VANCOUVER, British Columbia, April 15, 2021 (GLOBE NEWSWIRE) — TOWER ONE WIRELESS CORP. (CSE: TO) (OTCQB: TOWTF) (Frankfurt: 1P3N) (“Tower…
PORTLAND, Ore., April 15, 2021 (GLOBE NEWSWIRE) — Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) (“Golden Leaf” or the…
NASHVILLE, Tenn., April 15, 2021 (GLOBE NEWSWIRE) — Harrow Health, Inc. (NASDAQ: HROW) (“Harrow Health” or the “Company”), an ophthalmic-focused…
Phase 2/3 clinical trial for Tempol for the prevention of hospitalizations in patients with COVID-19 expected to initiate in the…
CAMBRIDGE, Mass., April 15, 2021 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic…
TECFIDERA was approved under the National Medical Products Administration priority review process evaluating therapies with urgent clinical needsMore than 500,000…
MENLO PARK, Calif., April 15, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly…
TUSTIN, Calif., April 15, 2021 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO) (the “company”), a dedicated biologics contract development…